BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 26, 2011
View Archived Issues
Delcasertib does not benefit patients with heart damage from reperfusion injury
Read More
New CSF-1-R inhibitor DCC-2909 shows promise to treat bone metastasis
Read More
In vivo data support evaluation of XP-23829 for treatment of RRMS
Read More
Phase II AMG-785 trial in postmenopausal osteoporosis meets primary endpoint
Read More
Gilead and MicroDose Therapeutx to develop MDT-637 for treatment of RSV infection
Read More
Low levels of dickkopf-related protein 3 may predict poor outcome in cervical cancer
Read More
KW-2450 suppresses tumor growth in vivo and advances in phase I/II trial in breast cancer
Read More
Glycoengineered CIFN derivatives display improved pharmacokinetics
Read More
Zhejiang Beta Pharma presents new protein kinase inhibitors for cancer
Read More
Novel FADK 1 inhibitors described by Boehringer Ingelheim
Read More
Novartis and Xenon Pharma design new acyl-CoA desaturase inhibitors
Read More
New inhibitors of leucine-rich repeat serine/threonine-protein kinase 2 claimed
Read More
U.S. researchers present novel Bcl-2 inhibitors for cancer
Read More
Clinuvel and EMA to meet regarding proposed MAA for Scenesse in EPP
Read More
Prana Biotechnology accelerates development of PBT-2
Read More
Hanmi Pharmaceuticals to acquire rights for KX-01 in selected Asian territories
Read More
Aduro BioTech raises funds to support development of CRS-207 and other vaccines
Read More
Spectrum Pharma receives FDA approval for ready-to-use formulation of Fusilev
Read More
Advanced Cell Technology seeks clearance for phase I/II retinal pigment epithelial cell trial
Read More
NanoBio gains rights to antigen for prevention of urinary tract infections
Read More
FDA orphan designation for NKTR-102 in ovarian cancer
Read More
CytRx expands enrollment in phase IIb tamibarotene trial in NSCLC
Read More
Daiichi Sankyo's Lixiana receives first approval in Japan
Read More
Halaven approved in Japan for inoperable and recurrent breast cancer
Read More
Mircera approved in Japan for renal anemia
Read More
Merrimack Pharma begins phase I MM-111 combination trial in solid tumors
Read More
